GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing

Tue, 11th Jan 2022 12:19

(Alliance News) - Stock prices in London were higher at midday on Tuesday as investors eagerly await Congressional testimony from Federal Reserve Chair Jerome Powell.

The Fed chief will highlight the central bank's efforts to fight inflation and stabilize the US economy at his confirmation hearing, according to testimony released Monday.

However, the Republican will likely also face questions about his ethics from a Democratic senator, after a media report raised further questions over whether a Fed official had traded securities to benefit from the upheaval caused by the Covid-19 pandemic in 2020.

Powell's testimony Tuesday before the Senate Banking Committee comes after President Joe Biden nominated him for a second term leading the central bank as the US economy deals with a wave of record-high inflation that's prompted critics to accuse the Fed of complacency.

The Fed's December minutes caused a stir last week, raising the possibility of an interest rate hike in March and revealing more-aggressive-than-expected discussions over further reducing the central bank's balance sheet.

The FTSE 100 was up 37.78 points, or 0.5%, at 7,483.03. The mid-cap FTSE 250 index was up 179.03 points, or 0.8%, at 23,180.84. The AIM All-Share index was up 5.58 points, or 0.4%, at 1,175.85.

The Cboe UK 100 index was up 0.4% at 743.06. The Cboe 250 was up 0.4% at 20,653.91 and the Cboe Small Companies up 0.6% at 15,612.24.

In Paris the CAC 40 stock index was up 1.2%, while the DAX 40 in Frankfurt was 0.1% lower.

Analysts at ActivTrades said: "Stock investors are likely to pay attention to what will happen on the other side of the Atlantic with today's hearing from Fed Chair Jerome Powell in the Senate Banking Committee as well as further comments from other Fed officials, ahead of tomorrow's highly awaited US consumer price index report.

"Should Powell give any hint of an even more aggressive desire to tighten by the US central bank, which could entail a rate hike in March, rather than in June, and faster unwinding of its balance sheet, then we can expect a more bullish US dollar, potentially challenging the November maximums."

New York was pointed to a higher open. The Dow Jones Industrial Average was called 0.3% higher, the S&P 500 up 0.4%, and the Nasdaq Composite up 0.5%, based on futures trading.

In the FTSE 100, Scottish Mortgage Trust was the best performer, up 4.3%, tracking a rise in high-profile US technology companies in which it holds shares. The trust holds a 5.2% stake in Elon Musk's Tesla and also has a 3.1% holding in Jensen Huang's Nvidia. Tesla and Nvidia were up 0.7% and 0.6% respectively in pre-market trade. Tesla had added 3.0% on Monday and Nvidia 0.6%.

Flutter Entertainment was up 3.7% after Citigroup double-upgraded the gambling firm to Buy from Sell. The Dublin-based company also said it completed the acquisition of bingo operator Tombola for an enterprise value of GBP402 million.

Dechra Pharmaceuticals was up 2.7%. The veterinary products company said it has agreed terms with Anivive Lifesciences to acquire the worldwide rights to verdinexor, used to treat of all forms and stages of canine lymphoma in dogs.

Under the terms of the agreement, Dechra will acquire the global product rights and a first right of refusal for other species along with the trademark Laverdia.

Phoenix Group Holdings was up 2.5% after the closed life funds consolidator said it completed GBP4.0 billion of bulk purchase annuity transactions in the second half of 2021.

The London-based company said it completed four bulk purchase annuity transactions comprising of GBP3.6 billion of external deals and a further GBP400 million tranche of the group's pearl pension scheme.

Phoenix said this equates to total bulk purchase annuity premiums of GBP5.5 billion contracted for the year. This has more than doubled when compared to its 2020 figure of GBP2.5 billion.

As a result, Phoenix said it now expects to deliver in excess of GBP1 billion of total new business long-term cash generation for 2021 which it added will more than offset a GBP800 million run-off of the in-force business.

Conversely, Unilever was among the worst blue-chip performers, down 0.9%, after Bank of America downgraded the consumer goods firm to Neutral from Buy.

In the FTSE 250, Darktrace was giving back earlier gains but was still the best performer, up 10%. The stock, which was demoted from the FTSE 100 in December, is now up almost 75% from its April listing price.

The cybersecurity firm said it continued to deliver strong growth across its customer base in the first half as it raised annual guidance.

In a trading update for the six months to December 31, Darktrace reported 40% growth in number of customers - adding 6,531 customers in the period.

Looking ahead, Darktrace now expects annual recurring revenue for financial 2022 to rise by between 37% and 38.5%, up from previous guidance of 34% to 36%. Further, net revenue is set to grow by 42% to 44%, up from 37% to 39% previously guided.

Micro Focus International was up 9.5% after Jefferies raised the Newbury-based software firm to Buy from Hold.

Hays was the third-best midcap stock, up 5.1%, after Credit Suisse double-upgraded the headhunter to Outperform from Underperform.

On AIM, Shoe Zone was up 20% after the discount footwear chain swung to a full-year profit despite stores only trading for 36 weeks.

For the year ended October 2, the Leicester-based retailer reported a pretax profit of GBP9.5 million, swinging sharply from a loss of GBP14.6 million in financial 2020. Revenue was down 2.8% to GBP119.1 million from GBP122.6 million the previous financial year.

Elsewhere, the UK Financial Conduct Authority said it will launch two probes this year into the provision of wholesale financial data by stock exchanges and credit ratings agencies.

The FCA said input it has received so far raised concerns that "limited competition in the markets for benchmarks and indices, credit ratings and trading data may increase costs for investors and affect investment choices."

The financial regulator said the first of the two investigations will begin this summer with a look in whether "complex contracts" for benchmarks and indices prevent switching to cheaper or better-quality alternatives. By the end of the year, the FCA will launch a second study looking at "whether high charges for access to credit ratings data is adding costs to investors and limiting new market entrants".

The FCA said that concerns have been raised that limited competition for wholesale trading data provided by trading venues such as stock exchanges "may increase costs and have an impact on the types of assets that investment managers buy and sell".

The pound was quoted at USD1.3600 at midday Tuesday, up from USD1.3567 at the London equities close Monday.

The euro was priced at USD1.1334, higher against USD1.1327 late Monday. Against the Japanese yen, the dollar was trading at JPY115.47, up from JPY115.14.

Brent oil was quoted at USD82.00 a barrel Tuesday at midday, up sharply from USD81.26 at the London equities close on Monday. Gold stood at USD1,806.40 an ounce, rising from USD1,795.34.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 Jun 2023 07:02

Dechra to be taken private in £4.5bn deal

(Sharecast News) - Dechra Pharmaceuticals said on Friday that it has agreed to be taken over in a £4.46bn deal.

Read more
22 May 2023 14:10

Dechra profit to be 10% below expectations amid EQT discussions

(Alliance News) - Investors were spooked by Dechra Pharmaceuticals PLC's "unscheduled" trading update, which warned it was likely to miss annual profit guidance.

Read more
22 May 2023 12:16

LONDON MARKET MIDDAY: Shares mixed amid US debt ceiling nerves

(Alliance News) - Stock prices in London were mixed at midday on Monday, as investors closely eye developments in US debt ceiling negotiations, as a June 1 deadline creeps ever closer.

Read more
22 May 2023 09:05

LONDON MARKET OPEN: UK govt sells NatWest shares; UK house prices rise

(Alliance News) - Stock prices in London opened higher on Monday, ahead of further talks in the US aimed at resolving a political stand-off that threatens to cause Washington to default on its debt.

Read more
22 May 2023 08:39

TOP NEWS: Dechra shares fall as firm warns US destocking to hit profit

(Alliance News) - Dechra Pharmaceuticals PLC on Monday warned it was likely to miss annual profit guidance, after a more "volatile and challenging" trading environment in 2023.

Read more
22 May 2023 07:53

LONDON BRIEFING: UK cuts NatWest stake below 40%, halved from peak

(Alliance News) - Stocks in London were called to open flat on Monday, after news that UK house prices hit a new record high in May and amid resumed talks to break the impasse over raising the US debt ceiling.

Read more
22 May 2023 07:43

Dechra warns on profits after volatile third quarter

(Sharecast News) - Animal health specialist Dechra Pharmaceuticals issued a profit warning on Monday morning, saying that the trading environment since January had been more volatile and challenging than it previously expected.

Read more
11 May 2023 11:58

EQT bid deadline for Dechra Pharmaceuticals pushed back

(Sharecast News) - Dechra Pharmaceuticals said on Thursday that a deadline for Swedish private firm EQT to either announce a firm intention to make an offer for the company or walk away has been extended.

Read more
11 May 2023 09:47

Dechra extends EQT takeover offer deadline by three weeks

(Alliance News) - Dechra Pharmaceuticals PLC on Thursday said it pushed back its put-up-or-shut-up deadline by three weeks for EQT X EUR SCSp and EQT X USD SCSp's possible takeover of the Cheshire-based veterinary pharmaceutical company.

Read more
21 Apr 2023 10:01

UPDATE: North Atlantic Smaller Cos "pleased" with Sureserve takeover

(Alliance News) - North Atlantic Smaller Cos Investment Trust PLC on Friday said it was "pleased" with Sureserve Group PLC, after it said it has reached a takeover agreement with Cap10 Partners.

Read more
21 Apr 2023 09:05

TOP NEWS: Sureserve surges on Cap10 GBP214 million takeover deal

(Alliance News) - Energy services provider Sureserve Group PLC on Friday said it has reached a takeover agreement with Cap10 Partners.

Read more
21 Apr 2023 08:40

UPDATE: Network International jumps on takeover battle

(Alliance News) - Network International Holdings PLC on Friday confirmed that it has received another takeover offer, this time from Brookfield Asset Management Ltd.

Read more
14 Apr 2023 16:55

LONDON MARKET CLOSE: Stocks upbeat on hopes of pause to US rate rises

(Alliance News) - Stocks in London ended a shorter week in the green on Friday, as investors became increasingly confident that the US Federal Reserve will soon call time on its hiking cycle.

Read more
14 Apr 2023 12:01

LONDON MARKET MIDDAY: Sterling tops USD1.25 on hope of peak Fed rates

(Alliance News) - Stock prices in London were in the green at midday on Friday, while sterling hit a 10-month-high against the dollar, as investors predict the Federal Reserve's rate rise cycle may soon come to an end.

Read more
14 Apr 2023 10:00

Dechra Pharmaceuticals surges on £4.6bn takeover approach

(Sharecast News) - Shares in Dechra Pharmaceuticals surged on Friday after it announced late on Thursday that it was in talks with Swedish private equity firm EQT about a possible £4.6bn takeover.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.